The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds
Table 1
Patients in Recife-Brazil and London-UK with rare and common forms of cervical precancer lesions plus a cervicitis control group showing the mean mRNA levels of Brn-3a and HPV E6 in cervical scrapes.